Menu

Emerge Diagnostics to Present on Obesity at RIMS 2015

PRESS RELEASES –

Expert MaryRose Reason, PhD will discuss workers’ comp implications to employers.


CARLSBAD, CA – April 21, 2015 – Emerge Diagnostics, the creator and manufacturer of the revolutionary EFA technology that helps employers and medical professionals better identify the age and location of soft tissue injuries to control work comp costs and improve return to work times, announced that it will highlight the impact of the new American Medical Association’s reclassification of obesity as a disease in a presentation at the 2015 RIMS meeting being held April 26-29 in New Orleans.

MaryRose Reaston, Emerge Diagnostics’ founder and chief science officer, will present on Monday, April 27 at 4:00 p.m. in Room 224, Masters level of the New Orleans Ernest N. Morial Convention Center. The presentation will cover the recent reclassification of obesity as a disease, the impact it will have on employers and how baseline testing can minimize workers’ compensation exposure under the Americans with Disabilities Act. Reaston’s presentation, entitled “AMA Reclassification of Obesity as a Disease: How it Affects Workers’ Compensation and Mandatory Reporting” will offer insight into the following areas:

  • The impact of court decisions related to the AMA reclassification of obesity
  • Steps employers can take to control resulting risk
  • Opportunities to prevent obesity as a work-related condition
  • How baseline and post-injury testing can reduce an employer’s work comp exposure

Emerge Diagnostics will conduct demonstrations of its Electrodiagnostic Functional Assessment (EFA) technology at RIMS 2015. To learn more and see how EFA is changing the future of work comp claims, visit Emerge at booth #2307 or click here.

About Emerge Diagnostics

Headquartered in San Diego, Emerge Diagnostics is delivering a new way to determine the location and age of soft tissue injuries. The Company’s technology provides the most comprehensive and actionable pre- and post-injury test to determine whether an injury actually arose in the workplace. Emerge Diagnostics works with employers, occupational health clinics and insurance carriers/TPAs  to create better patient outcomes and reduced costs. Emerge is leading the way with technological development and ongoing innovation to improve workplace injury outcomes and return-to-work times. For more information about Emerge Diagnostics, visit www.emergedx.com and follow us on Twitter @emergedx.

Media Contact: Deborah Jondall, +1.619.417.8443, djondall@san.rr.com